The variant Creutzfeldt-Jakob Disease: Risk, uncertainty or safety in the use of blood and blood derivatives?
Open Access
- 1 January 2008
- journal article
- Published by International Medical Publisher (Fundacion de Neurociencias) in International Archives of Medicine
- Vol. 1 (1), 9
- https://doi.org/10.1186/1755-7682-1-9
Abstract
It has been long since French physician Jean-Baptiste Denys carried out the first successful blood transfusion to a human being. Using bird feathers as canules, sheep blood was transfused to a young man. The patient died soon after Denys' treatment and Denys was accused of murder. In the XXI century, known as the biotechnology century, we face new challenges in Medicine. New emerging and reemerging diseases, such as Creutzfeldt-Jakob disease (CJD) or "mad cow disease" and its human variant (vCJD), challenge the biosafety aspects of a widely extended and extremely useful technique, that is, the perfusion of blood, of its derived components and of other pharmacological products obtained from plasma. To face these new challenges we need innovative prevention strategies.Keywords
This publication has 33 references indexed in Scilit:
- Prion Infection of Muscle Cells In VitroJournal of Virology, 2007
- Impact of vCJD on blood supplyBiologicals, 2007
- Long term survival in a patient with variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulphateJournal of Neurology, Neurosurgery & Psychiatry, 2006
- The Expanding Universe of Prion DiseasesPLoS Pathogens, 2006
- Evolution of Artificial Cells Using Nanobiotechnology of Hemoglobin Based RBC Blood Substitute as an ExampleArtificial Cells, Blood Substitutes, and Immobilization Biotechnology, 2006
- Toward 21st Century Blood Component Replacement Therapeutics: Artificial Oxygen Carriers, Platelet Substitutes, Recombinant Clotting Factors, and OthersArtificial Cells, Blood Substitutes, and Immobilization Biotechnology, 2006
- Variant Creutzfeldt–Jakob disease transmission by plasma products: assessing and communicating risk in an era of scientific uncertaintyVox Sanguinis, 2005
- Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from bloodThe Lancet, 2004
- Prevalence of lymphoreticular prion protein accumulation in UK tissue samplesThe Journal of Pathology, 2004
- Novel Proteinaceous Infectious Particles Cause ScrapieScience, 1982